Liver protection by hypothermic perfusion at different temperatures during total vascular exclusion

Liver Int. 2006 May;26(4):486-93. doi: 10.1111/j.1478-3231.2006.01248.x.

Abstract

Introduction: In situ hypothermic perfusion (HP) can be applied to attenuate ischemia and reperfusion (I/R) injury during liver resection under total vascular exclusion (TVE). This study examines the protective effect of cooling by HP at 20 and 28 degrees C as compared with no HP during TVE in a porcine liver I/R model.

Methods: Twenty-one pigs underwent 60 min TVE of the liver followed by 24 h reperfusion. HP was performed via the portal vein using ringerlactate solution of 4 degrees C. Pigs were assigned to three groups: TVE without HP (no-HP, n=9), TVE with HP at 28 degrees C (HP-28, n=6) and TVE with HP at 20 degrees C (HP-20, n=6).

Results: Perfusion volumes during TVE were 5.1+/-0.5 and 17.3+/-1.7 l in HP-28 and HP-20, respectively (P<0.05). Aspartate aminotransferase (AST) after 24 h reperfusion was 1172+/-440 U/l in no-HP as compared with 223+/-69 and 180+/-22 U/l in HP-28 and HP-20, respectively (P<0.05). No differences in liver function or histopathology were found between the HP-28 and HP-20 groups.

Conclusions: HP at 20 degrees C is equally effective in preserving liver function and preventing hepatocellular injury under TVE as compared with HP at 28 degrees C. HP at 28 degrees C is advised, because of the lesser perfusion volume necessary for cooling of the liver.

MeSH terms

  • Animals
  • Aspartate Aminotransferases / metabolism
  • Epithelial Cells / metabolism
  • Epithelial Cells / pathology
  • Hemodynamics / physiology
  • Hepatectomy / methods
  • Hypothermia, Induced*
  • Inflammation / pathology
  • Inflammation / physiopathology
  • Interleukin-6 / metabolism
  • Liver / blood supply*
  • Liver / physiopathology*
  • Liver / surgery
  • Male
  • Reperfusion Injury / pathology
  • Reperfusion Injury / physiopathology
  • Reperfusion Injury / prevention & control*
  • Swine
  • Temperature*
  • Time Factors

Substances

  • Interleukin-6
  • Aspartate Aminotransferases